Skip to content

A Multi-omics Study of Host–Gut Microbiota–Metabolite Interactions in the Aging Process of the Chinese Population

A Multi-omics Study of Host–Gut Microbiota–Metabolite Interactions in the Aging Process of the Chinese Population

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130953
Enrollment
Unknown
Registered
2026-08-26
Start date
2026-08-31
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adipose aging and multi-organ aging

Interventions

Generally healthy older adults:None

Sponsors

Second Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1:Han Chinese males. 2:Young group: age 20–30 years; Elderly group: age >=65 years. 3:The overall health status is good, as confirmed through medical history taking and physical examination. 4:No antibiotics, probiotic preparations, or health supplements containing prebiotics have been taken within the past 1 month. 5:No history of severe chronic diseases, such as diabetes mellitus, neurological disorders (e.g., Alzheimer's disease, Parkinson's disease), cardiovascular or cerebrovascular diseases, or malignant tumors. 6:Non-smokers. 7:Voluntarily participate in the study and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1:Diagnosis of known organic intestinal disorders (e.g., inflammatory bowel disease, irritable bowel syndrome, colorectal cancer, etc.). 2:Has undergone gastrointestinal surgery within the past 1 month. 3:Patients with severe hepatic or renal insufficiency. 4:Long-term use of medications that may affect the gut microbiota, such as immunosuppressants, glucocorticoids, or proton pump inhibitors. 5:History of acute infection, diarrhea, or constipation within the past 1 month. 6:History of alcohol or drug abuse. 7:Other circumstances in which the investigator deems the subject unsuitable for participation in this trial.

Design outcomes

Primary

MeasureTime frame
Fecal microbiota;Fecal metabolites;Peripheral Blood Leukocyte Telomere Length;

Countries

China

Contacts

Public ContactChai Renjie

Second Affiliated Hospital of Guangzhou Medical University

yuchencrj@163.com+86 20 34152298

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026